New England Research & Management, Inc. Merck & Co., Inc. Transaction History

New England Research & Management, Inc.

  • $197 Million
  • Q4 2024

A detailed history of New England Research & Management, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, New England Research & Management, Inc. holds 24,160 shares of MRK stock, worth $2.21 Million. This represents 1.22% of its overall portfolio holdings.

Number of Shares
24,160
Previous 23,743 1.76%
Holding current value
$2.21 Million
Previous $2.7 Million 10.87%
% of portfolio
1.22%
Previous 1.27%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 23, 2025
BUY
$96.31 - $114.76 $40,161 - $47,854
417 Added 1.76%
24,160 $2.4 Million
Q3 2024

Oct 07, 2024
BUY
$111.15 - $128.97 $602,988 - $699,662
5,425 Added 29.62%
23,743 $2.7 Million
Q2 2024

Jul 09, 2024
BUY
$123.8 - $132.96 $311,852 - $334,926
2,519 Added 15.94%
18,318 $2.27 Million
Q1 2024

Apr 16, 2024
BUY
$113.24 - $131.95 $53,789 - $62,676
475 Added 3.1%
15,799 $2.09 Million
Q4 2023

Feb 06, 2024
SELL
$100.18 - $109.02 $60,108 - $65,412
-600 Reduced 3.77%
15,324 $1.67 Million
Q3 2023

Oct 10, 2023
SELL
$102.95 - $114.33 $41,180 - $45,732
-400 Reduced 2.45%
15,924 $1.64 Million
Q2 2023

Jul 05, 2023
SELL
$108.61 - $118.38 $16,182 - $17,638
-149 Reduced 0.9%
16,324 $1.88 Million
Q1 2023

Apr 06, 2023
SELL
$102.94 - $114.86 $1.17 Million - $1.31 Million
-11,394 Reduced 40.89%
16,473 $1.75 Million
Q4 2022

Jan 09, 2023
SELL
$87.44 - $112.11 $305,340 - $391,488
-3,492 Reduced 11.14%
27,867 $3.09 Million
Q3 2022

Oct 06, 2022
BUY
$84.53 - $94.96 $162,720 - $182,798
1,925 Added 6.54%
31,359 $2.7 Million
Q2 2022

Jul 20, 2022
BUY
$83.49 - $94.64 $237,863 - $269,629
2,849 Added 10.72%
29,434 $2.68 Million
Q1 2022

Apr 20, 2022
SELL
$73.51 - $82.4 $31,168 - $34,937
-424 Reduced 1.57%
26,585 $2.18 Million
Q4 2021

Jan 05, 2022
SELL
$72.28 - $90.54 $69,316 - $86,827
-959 Reduced 3.43%
27,009 $2.07 Million
Q3 2021

Oct 08, 2021
SELL
$71.68 - $78.83 $3,584 - $3,941
-50 Reduced 0.18%
27,968 $2.1 Million
Q2 2021

Jul 15, 2021
SELL
$70.31 - $77.77 $267,388 - $295,759
-3,803 Reduced 11.95%
28,018 $2.18 Million
Q1 2021

Apr 16, 2021
BUY
$68.86 - $81.11 $166,159 - $195,718
2,413 Added 8.21%
31,821 $2.45 Million
Q4 2020

Jan 07, 2021
SELL
$71.77 - $79.65 $1,004 - $1,115
-14 Reduced 0.05%
29,408 $2.41 Million
Q3 2020

Oct 08, 2020
SELL
$73.18 - $82.95 $413,320 - $468,501
-5,648 Reduced 16.1%
29,422 $2.44 Million
Q2 2020

Jul 15, 2020
BUY
$70.42 - $80.13 $623,217 - $709,150
8,850 Added 33.75%
35,070 $2.71 Million
Q1 2020

Jun 15, 2020
BUY
$63.36 - $87.82 $196,416 - $272,242
3,100 Added 13.41%
26,220 $2.02 Million
Q4 2019

Jan 14, 2020
SELL
$77.58 - $87.54 $13,576 - $15,319
-175 Reduced 0.75%
23,120 $2.1 Million
Q3 2019

Nov 04, 2019
SELL
$76.08 - $82.93 $34,236 - $37,318
-450 Reduced 1.9%
23,295 $1.96 Million
Q2 2019

Jul 09, 2019
SELL
$69.84 - $81.59 $38,412 - $44,874
-550 Reduced 2.26%
23,745 $1.99 Million
Q1 2019

Apr 03, 2019
SELL
$69.58 - $79.36 $258,837 - $295,219
-3,720 Reduced 13.28%
24,295 $2.02 Million
Q4 2018

Jan 11, 2019
SELL
$65.24 - $75.71 $39,144 - $45,425
-600 Reduced 2.1%
28,015 $2.14 Million
Q3 2018

Oct 03, 2018
SELL
$57.69 - $67.84 $72,112 - $84,800
-1,250 Reduced 4.19%
28,615 $2.03 Million
Q2 2018

Jul 05, 2018
SELL
$50.83 - $59.72 $91,494 - $107,496
-1,800 Reduced 5.68%
29,865 $1.81 Million
Q1 2018

Apr 17, 2018
BUY
$50.96 - $59.23 $203,840 - $236,920
4,000 Added 14.46%
31,665 $1.73 Million
Q4 2017

Jan 09, 2018
BUY
$51.62 - $61.64 $85,173 - $101,706
1,650 Added 6.34%
27,665 $1.56 Million
Q3 2017

Oct 25, 2017
BUY
$58.67 - $63.13 $1.53 Million - $1.64 Million
26,015
26,015 $1.67 Million

Others Institutions Holding MRK

# of Institutions
3,956
Shares Held
1.94B
Call Options Held
16M
Put Options Held
15M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $231B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track New England Research & Management, Inc. Portfolio

Follow New England Research & Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Research & Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on New England Research & Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email